
Elie Ritch
@sudomanx
Bioinformatician by day, computational biologist by night. Full time grad student.
ID: 841542739334381569
14-03-2017 06:53:18
147 Tweet
311 Takipçi
1,1K Takip Edilen





COMPare We sent correction letters on every misreported clinical trial in the world's biggest medical journals, to see how the editors - and the trialists - would react. What happened next? trialsjournal.biomedcentral.com/articles/10.11… trialsjournal.biomedcentral.com/articles/10.11… ...






Our latest, led by Elie Ritch @cherberts1 & Simon Fu, dissecting mismatch repair defective metastatic PCa via plasma cfDNA targeted and whole exome sequencing – published in Clinical Cancer Research: bit.ly/35kaC30 1/6


Researchers in Alex Wyatt's (Alex Wyatt) lab at the Vancouver Prostate Centre have shown that mismatch repair-defective metastatic #ProstateCancer can be identified and characterized using plasma circulating tumour DNA. Elie Ritch @cherberts1 bit.ly/2YegXdJ

Social isolation isn't gonna stop the Wyatt lab team from supporting #PlaidforDad 😷 Vancouver Prostate Centre Alex Wyatt


👉 Need help understanding DevOps? Let David Hasselhoff FLAVOR FLAV @Carole_Baskin help simplify @AWScloud @Kubernetesio Docker for you. #CelebritiesExplainDevOps Backstory: cto.ai/blog/celebriti…


Too many papers focus on the promise of liquid biopsy without recognizing the limitations. Here’s @cherberts1 and my take on how ctDNA fraction (tumor purity) and assay design combine to constrain what types of genomic alteration can be detected in ctDNA. authors.elsevier.com/a/1dKt28Z12yMG…

Happy to share our study on the indolent genomics of lung recurrent HSPC! bit.ly/3N7AapK. Kim Van der Eecken meCurt Herberts Alex Wyatt Piet Ost This is a rare underexplored subtype of PCa, with some evidence supporting a distinct clinical trajectory from liver mets.🧵👇1/7


Here’s a paper from our team in npj Journals Precision Oncology, led by newly-minted PhD Dr. Elie Ritch (Elie Ritch), using machine learning to classify prostate cancer ctDNA samples by DNA damage repair phenotype on the basis of mutational signatures. rdcu.be/c7tvo
